Health
Guillain-Barré syndrome: Why experts are still “confident” in J&J – Inverse
The chances of developing Guillain-Barré Syndrome (GBS) the Johnson & Johnson Covid-19 vaccine are small; what you need to know…
When news broke early this week that there was a possible association
between the Johnson & JohnsonCovid-19 vaccine and rare neurological disorder, people were understandably alarmed. Around 12.5 million people in the United States have received the one-dose…
Continue Reading
-
Noosa News20 hours agoPlastic-free fest | Noosa Today
-
Noosa News18 hours agoSXSW Sydney Unlocked – Concrete Playground
-
Noosa News11 hours agoAttorney-General appeals ‘plainly unjust’ sentence for teen who caused triple fatal crash
-
Business10 hours agoWhat is Macquarie’s price target for Evolution Mining shares after its FY25 result?